Q2 lyhyesti:
April-June 2024 highlights
• Invoicing increased by 5.3 % to EUR 952.2 (904.3). On a constant currency basis, invoicing
increased by 5.5% and was EUR 954.4 million.
• Net sales increased by 13.0% to EUR 439.4 (389.0) million. On a constant currency basis, net sales
increased by 13.3% and were EUR 440.6 million.
• Adjusted EBIT was EUR 5.1 (3.4) million. On a constant currency basis, the adjusted EBIT was EUR
5. 1 million.
• EBIT was EUR 5.7 (3.2) million and included adjusting items of EUR 0.5 (-0.2) million mainly related
to the implementation costs of the ERP investment and to dose dispensing business in Sweden. On
a constant currency basis, EBIT was EUR 5.7 million.
• Profit for the period totalled EUR 2.0 (1.2) million and earnings per share were EUR 0.01 (0.01).
• From Q2 onwards, implementation costs in cloud computing arrangement relating to ERP
investment, announced on 10 January 2024, are reported as adjusting items
Puolivuosikatsaus:
Esitys: